Skip to main content

Drug Interactions between Cedax and torsemide

This report displays the potential drug interactions for the following 2 drugs:

Edit list (add/remove drugs)

Interactions between your drugs

Moderate

torsemide ceftibuten

Applies to: torsemide and Cedax (ceftibuten)

MONITOR: Limited data suggest that furosemide and possibly other loop diuretics may potentiate the nephrotoxicity of some cephalosporins. The exact mechanism of interaction is unknown, although furosemide has been shown to increase the plasma concentrations and/or reduce the clearance of several cephalosporins such as cephaloridine and ceftazidime. Data from an early study identified an association between diuretic use and acute renal failure during cephaloridine treatment. Specifically, 9 out of 36 patients who developed acute renal failure while on cephaloridine were also receiving a diuretic (primarily furosemide). Other risk factors included shock, infection, excessive dosage of cephaloridine, and concomitant use of other potentially nephrotoxic drugs. Several case reports have also suggested an increased risk of nephrotoxicity with the combination of furosemide and cephaloridine or cephalothin, and one study found that administration of furosemide or ethacrynic acid increased both the incidence and extent of proximal renal tubular necrosis in cephaloridine-treated mice and rats. In contrast, a study conducted in patients with preexisting moderate renal impairment found no effect of furosemide on the serum half-life of cefoxitin, and glomerular filtration rate was not affected during concomitant administration of cefoxitin and furosemide.

MANAGEMENT: Although data are primarily limited to cephaloridine, which is no longer commercially marketed, caution may be advisable in patients receiving a loop diuretic in combination with other cephalosporins. Renal function should be monitored, particularly when high dosages are used or when these medications are administered in the elderly or patients with preexisting renal impairment.

References

  1. Korn A, Eichler HG, Gasic S (1986) "A drug interaction study of ceftriaxone and frusemide in healthy volunteers." Int J Clin Pharmacol Ther Toxicol, 24, p. 262-4
  2. Lawson DH, Macadam RF, Singh H, et al. (1972) "Effect of furosemide on antibiotic-induced renal damage in rats." J Infect Dis, 126, p. 593-600
  3. Tilstone WJ, Semple PF, Lawson DH, Boyle JA (1977) "Effects of furosemide on glomerular filtration rate and clearance of practolol, digoxin, cephaloridine, and gentamicin." Clin Pharmacol Ther, 22, p. 389-94
  4. Trollfors B, Norrby R, Kristianson K, Nilsson NJ (1978) "Effects on renal function of treatment with cefoxitin alone or in combination with furosemide." Scand J Infect Dis, 13, p. 73-7
  5. Simpson IJ (1971) "Nephrotoxicity and acute renal failure associated with cephalothin and cephaloridine." N Z Med J, 74, p. 312-5
  6. Dodds MG, Foord RD (1970) "Enhancement by potent diuretics of renal tubular necrosis induced by cephaloridine." Br J Pharmacol, 40, p. 227-36
  7. Norrby R, Stenqvist K, Elgefors B (1976) "Interaction between cephaloridine and furosemide in man." Scand J Infect Dis, 8, p. 209-12
  8. Chrysos G, Gargalianos P, Lelekis M, Stefanou J, Kosmidis J (1995) "Pharmacokinetic interactions of ceftazidime and frusemide." J Chemother, 7 Suppl, p. 107-10
View all 8 references

Switch to consumer interaction data

Drug and food interactions

Moderate

ceftibuten food

Applies to: Cedax (ceftibuten)

ADJUST DOSING INTERVAL: Food reduces the oral absorption and bioavailability of ceftibuten. According to the product labeling, administration of ceftibuten oral suspension with a high-fat breakfast decreased the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) by 26% and 17%, respectively. Administration of ceftibuten capsules with a standardized breakfast decreased the mean peak plasma concentration (Cmax) and area under the concentration-time curve (AUC) by 18% and 8%, respectively.

MANAGEMENT: To ensure maximal oral absorption, ceftibuten oral suspension should be taken at least two hours before or one hour after a meal.

References

  1. (2001) "Product Information. Cedax (ceftibuten)." Schering-Plough

Switch to consumer interaction data

Therapeutic duplication warnings

No warnings were found for your selected drugs.

Therapeutic duplication warnings are only returned when drugs within the same group exceed the recommended therapeutic duplication maximum.


Report options

Loading...
QR code containing a link to this page

Drug Interaction Classification

These classifications are only a guideline. The relevance of a particular drug interaction to a specific individual is difficult to determine. Always consult your healthcare provider before starting or stopping any medication.
Major Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit.
Moderate Moderately clinically significant. Usually avoid combinations; use it only under special circumstances.
Minor Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan.
Unknown No interaction information available.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.